Pantoprazole Gastro-Resistant & Domperidone Prolonged Release Capsules IP – Dual-Action Relief for Acid Reflux & Motility Disorders.
SULFLUX DSR: The Dual combination of Pantoprazole (EC) 40 mg + Domperidone (Sustained Release) IP 30 mg is designed for enhanced acid suppression and gastric motility improvement:
Pantoprazole is a proton pump inhibitor (PPI) that inhibits the H+/K+ ATPase pump, effectively reducing stomach acid production.
Domperidone is a dopamine D2 receptor antagonist that promotes gastric emptying and prevents nausea & bloating by blocking dopamine receptors in the gut.
Recommended By Specialists:
✅Gastroenterologists: IT is mainly used to prefer this combination to treat the disease associated with peptic ulcers, gastritis, and delayed gastric emptying
✅General Physician: It mainly differs in treating the disease associated with common digestive issues like bloating, acidity, and nausea
Key Benefits of Pantoprazole Gastro-Resistant & Domperidone Prolonged Release Capsules IP – SULFLUX DSR
✅Instant & Sustained Acid Control – Pantoprazole provides prolonged acid suppression, while Domperidone IR ensures rapid symptom relief, making it ideal for GERD, dyspepsia, and acid reflux.
✅Optimized Prokinetic Support – The Domperidone dual-release formulation offers immediate gastric emptying support and sustained prokinetic action, reducing bloating, nausea, and regurgitation.
✅Superior to PPI Monotherapy – The combination effectively prevents acid reflux and motility dysfunction, ensuring faster and longer-lasting symptom relief compared to PPIs alone.
INDICATIONS:
✅Gastroesophageal Reflux Disease (GERD)
✅Functional Dyspepsia
✅Chronic Acid Reflux
✅Post-Meal Bloating & Nausea
✅Delayed Gastric Emptying











